Pembrolizumab in the treatment of metastatic non-small cell lung cancer: a review of current evidence

Immune checkpoint inhibitors (ICPIs) are considered one of the most important breakthroughs in cancer treatment of the past decade; notably, different studies of programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) inhibitors have reported impressive clinical activity and dur...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Ther Adv Respir Dis
Main Authors: Rihawi, Karim, Gelsomino, Francesco, Sperandi, Francesca, Melotti, Barbara, Fiorentino, Michelangelo, Casolari, Laura, Ardizzoni, Andrea
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2017
Assuntos:
Reviews
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5933587/
https://ncbi.nlm.nih.gov/pubmed/28818019
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753465817725486
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados